Project Grant HT94252410969
Award Date
11/1/24
Completion Date
10/31/27
Dollars Obligated
$1.5M
Federal Agency
Defense Health Agency
Awardee
Purdue University (YRXVL4JYCEF5)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
West Lafayette, IN, USA
Similar Awards
This federal Project Grant award of $325,142, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports the development of a clinical-grade spinal cord neuroprosthesis to alleviate locomotor deficits in people with Parkinson's disease. The award, which has a performance period from September 1, 2025 to August 31, 2028, is being provided to Onward Medical Inc., a for-profit organization located in Boston, MA. The goal of this...
This federal Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), provides $1,749,465.00 to Bright Uro, Inc. to develop a catheter-free, extended-monitoring urodynamics device for quantitative, real-time bladder management in spinal cord-injured patients. The award period runs from July 1, 2024 to June 1, 2026. The goal of this project is to create an innovative medical device that can assist in the care and treatment...
This federal Project Grant award for $773,399.00, funded by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420), supports research at Case Western Reserve University to investigate neuromodulation for improving bladder function in a large animal model of spinal cord injury (SCI). The award, which runs from September 30, 2024 to September 29, 2027, will enable the university's researchers to explore innovative approaches to...
This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...
This $487,623 federal Project Grant, awarded on September 30, 2023 by the Defense Health Agency (DHA) under the Military Medical Research and Development CFDA program (12.420), supports research on the prevalence of neuropathic pain pathophysiology associated with ankle fracture. The award recipient is the Trustees of Indiana University, doing business as Indiana University, a major public research university with extensive expertise in biomedical sciences research. The project aims to advance...
The Department of the Army Medical Command awarded Purdue University a $2,431,591 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2022 through September 2026 to study the Role of Comorbid Military-Relevant Stressors in Osteoarthritis. Through this award, Purdue University researchers will investigate the impact of psychological and physiological stress experienced by military service members on the development...
The federal Project Grant award of $1,793,411 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Rehabilitation Institute of Chicago (doing business as Shirley Ryan AbilityLab), a non-profit hospital and research institute. The funding will support a research project titled "SAFETY AND EFFICACY OF AMPAKINES FOR IMPROVEMENT OF BLADDER FUNCTION IN INDIVIDUALS WITH SCI" over the period of July 1, 2024 to June 30,...
This $938,053 federal project grant awarded by the Defense Health Agency on September 30, 2023 under the Military Medical Research and Development program (CFDA 12.420) supports research on the prevalence of neuropathic pain pathophysiology associated with ankle fracture. The awardee, Trustees of Indiana University, will conduct this 4-year research project to advance scientific understanding and develop new treatment approaches for this condition affecting military service members and veterans....
This federal Project Grant award of $250,000 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The funding will support research at the University of Notre Dame DU Lac aimed at "TARGETING NEURAL STEM CELL QUIESCENCE TO PROMOTE REMYELINATION", with a project period from September 1, 2024 to August 31, 2026. The research focuses on developing innovative approaches to address critical medical challenges facing military...
The Defense Health Agency awarded Trustees of Indiana University, doing business as Indiana University, a $704,674 Project Grant under the Military Medical Research and Development federal grant program (CFDA 12.420) to develop a preclinical model for gene therapy of Fanconi anemia group C. Through this award with a completion date of September 29, 2026, Indiana University will perform research to investigate medical solutions for battlefield conditions by developing a preclinical model for a...